CTS
CTS Corporation
CTS's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CTS overall, supported by stronger valuation and stronger modeled upside.
CTS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
CTS's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CTS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $61.01 | — |
| Cheap | 22x | $54.94 | -10% |
| Current | 24x | $61.01 | — |
| Fair | 25x | $62.16 | +1.9% |
| Expensive | 29x | $73.78 | +21% |
Historical ranges are pointers, not guarantees.
CTS's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 21x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CTS in the historical PE scenario, which offers more potential upside but is not a forecast.
CTS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
CTS has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.85 | +13% |
| Q3 2026 | $2.53 | +29% |
| Q2 2026 | $2.38 | +13% |
| Q1 2026 | $2.34 | +19% |
| Q4 2025 | $2.19 | +16% |
| Q3 2025 | $1.96 | +1% |
| Q2 2025 | $2.11 | +19% |
| Q1 2025 | $1.97 | +16% |
| Q4 2024 | $1.89 | -1.6% |
CTS earned $2.53 per share over the past year, up 29% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CTS on earnings, with more consistent year-over-year improvement.
CTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $149.6M | +4.6% |
| Q2 2026 | $144.8M | +7% |
| Q1 2026 | $139.2M | +11% |
| Q4 2025 | $137.3M | +7.7% |
| Q3 2025 | $143M | +8% |
| Q2 2025 | $135.3M | +4% |
| Q1 2025 | $125.8M | 0% |
| Q4 2024 | $127.4M | +2.2% |
CTS's revenue has grown year over year for eight quarters in a row: $150M last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.4 points |
| Q2 2026 | 19% | +1.7 points |
| Q1 2026 | 16% | +2.8 points |
| Q4 2025 | 17% | +1.6 points |
| Q3 2025 | 15% | -1.6 points |
| Q2 2025 | 17% | +3.2 points |
| Q1 2025 | 13% | +1.4 points |
| Q4 2024 | 15% | +1.9 points |
CTS's operating margin was 17% last quarter, up 2.4 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CTS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CTS on profitability, with a higher operating margin.
CTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $41.1M | +70% |
| Q2 2026 | $28.9M | +15% |
| Q1 2026 | $12.3M | +11% |
| Q4 2025 | $26M | +31% |
| Q3 2025 | $24.2M | -23% |
| Q2 2025 | $25.1M | +67% |
| Q1 2025 | $11.1M | -23% |
| Q4 2024 | $19.9M | -31% |
CTS's free cash flow has been positive every quarter for seven years: $108M over the past year, up 35% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CTS on cash flow, with more consistent year-over-year improvement.
CTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +8K shares |
| 1 year | -2.4% | -710K shares |
| 3 years | -8.2% | -2.6M shares |
| 5 years | -11% | -3.5M shares |
| Available history | -13% | -4.2M shares |
CTS has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.3M |
| Q2 2026 | $3.4M |
| Q1 2026 | $8.6M |
| Q4 2025 | $16.6M |
| Q3 2025 | $16.6M |
| Q2 2025 | $16.5M |
| Q1 2025 | $6.5M |
| Q4 2024 | $7.8M |
CTS spent $32M buying back its own shares over the past year, down 33% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CTS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | -0.0x | Net Cash |
CTS has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 49.7 | Neutral |
CTS's weekly RSI is 54 (neutral) and its Stochastic is 50 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CTS PE vs Technology Sector
| Metric | CTS | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 28x | 13% below |
| PE % | 43 | 35 | 8 pts above |
CTS is trading at 24x earnings, a 13% discount to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over CTS on valuation relative to its sector.
CTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.3 | 4.6% above |
| 20 week MA | $59.4 | 2.7% above |
| 50 week MA | $55.8 | 9.3% above |
| 100 week MA | $49.4 | 24% above |
| 200 week MA | $47.6 | 28% above |
CTS has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $33.7 | +14% |
| 2021 | $33.7 | $36.3 | +7.8% |
| 2022 | $36.3 | $38.9 | +7.1% |
| 2023 | $38.9 | $43.7 | +12% |
| 2024 | $43.7 | $53.1 | +21% |
| 2025 | $53.1 | $44.5 | -16% |
| 2026 YTD | $44.5 | $61.0 | +37% |
CTS has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.